APA

Jacot W., Pons E., Frenel J., Guiu S., Levy C., Heudel P. E., Bachelot T., D'Hondt V., Darlix A., Firmin N., Romieu G., Thezenas S. & Dalenc F. (20171120). Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases. : Breast cancer research and treatment.

Chicago

Jacot William, Pons Elvire, Frenel Jean-Sébastien, Guiu Séverine, Levy Christelle, Heudel Pierre Etienne, Bachelot Thomas, D'Hondt Véronique, Darlix Amélie, Firmin Nelly, Romieu Gilles, Thezenas Simon and Dalenc Florence. 20171120. Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases. : Breast cancer research and treatment.

Harvard

Jacot W., Pons E., Frenel J., Guiu S., Levy C., Heudel P. E., Bachelot T., D'Hondt V., Darlix A., Firmin N., Romieu G., Thezenas S. and Dalenc F. (20171120). Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases. : Breast cancer research and treatment.

MLA

Jacot William, Pons Elvire, Frenel Jean-Sébastien, Guiu Séverine, Levy Christelle, Heudel Pierre Etienne, Bachelot Thomas, D'Hondt Véronique, Darlix Amélie, Firmin Nelly, Romieu Gilles, Thezenas Simon and Dalenc Florence. Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases. : Breast cancer research and treatment. 20171120.